Deloitte appoints Asif Dhar as head of US life sciences and health care practice

09 July 2020 2 min. read
More news on

Deloitte has appointed Asif Dhar as the leader of its US life sciences and health care (LSHC) practice. He will remain based in the Washington, DC area.

In the role, Dhar will oversee the practice’s strategic direction and implement go-to-market strategies for the practice’s business lines, which includes audit, tax, consulting, and advisory. Deloitte US’ LSHC practice has more than 10,000 professionals, and serves virtually all of the industry’s Fortune 500 firms.

Dhar replaces Doug Beaudoin, who was recently appointed as the firm’s chief information officer.

Dhar has been with Deloitte since 2007, and has been a principal since 2011. He previously held the role of federal health solutions leader, and also served as LSHC’s chief health informatics officer.

In his time with the firm, he has supported numerous industry clients with their transformation journeys, as well as public sector clients. Dhar also helped to establish Deloitte’s ConvergeHEALTH offering, which unites next-gen platforms, industry expertise, and novel collaboration models.Asif Dhar, Industry Leader, DeloittePrior to Deloitte, Dhar spent two years as a senior associate at consulting firm Booz Allen Hamilton, and two years as a physician executive at healthcare IT solutions firm Cerner Corporation.

He holds a BA and MBA from the University of Chicago, as well as an MD from the University of Illinois College of Medicine.

"With his deep knowledge of both the life sciences and health care industries, I am confident in his ability to lead through today's tumultuous times and bring pragmatic, implementable solutions to our clients," said Seema Pajula, vice chairman and US industries and insights leader for Deloitte.  

Dhar commented, "This is a pivotal moment in history and I am humbled to lead our practice of dedicated professionals as we help our clients address multigenerational health and equity challenges while we respond to the crisis of coronavirus-19. Deloitte's 'Future of Health' vision suggests a radical transformation of the industry – one that is more virtual, organized around the community, compassionate, equitable, predictive, and preventative.”